[11C]choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen.
about
Oligometastatic prostate cancer: Metastases-directed therapy?Target Definition in Salvage Radiotherapy for Recurrent Prostate Cancer: The Role of Advanced Molecular ImagingImaging biomarkers in prostate cancer: role of PET/CT and MRI.PET Tracers Beyond FDG in Prostate Cancer.PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.68Ga-PSMA PET/CT for the detection of bone metastasis in recurrent prostate cancer and a PSA level <2 ng/ml: Two case reports and a literature review.Comparison of meta-analyses among elastosonography (ES) and positron emission tomography/computed tomography (PET/CT) imaging techniques in the application of prostate cancer diagnosis.Significant increase in detection of prostate cancer recurrence following radical prostatectomy with an early imaging acquisition protocol with ¹⁸F-fluorocholine positron emission tomography/computed tomography.Writing PET into existence.Trigger pSA predicting recurrence from positive choline PET/CT with prostate cancer after initial treatment.Pre-treatment F-choline PET/CT is prognostic for biochemical recurrence, development of bone metastasis, and cancer specific mortality following radical local therapy of high-risk prostate cancerPET/MRI and prostate cancerProstate cancer recurrence: can PSA guide imaging?[11C]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy11C-Choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients
P2860
Q26740069-A42C2FAD-FD39-46CD-B8CF-2A41F2D682A6Q28074669-1E94F0A2-0CAF-4463-9438-C594F7CD6300Q38321182-C3F9B2AB-F1BA-4178-ABF0-AE59B5F45CC5Q39003086-667B7151-14DA-4136-AFF4-CF0DA0ED3E4AQ39242140-7E444020-CD10-4A76-A50C-E58D97619AD8Q39419798-E7422E07-FBC7-46A9-9097-4C7E50808248Q52990619-AD6AB4DD-E8C6-405C-9CA6-7DE6CFE30839Q53031298-CDAF17D3-C50B-4B49-8782-244E3C1A9943Q53094162-C56730A4-C8BD-4793-8C15-2808E83C4F28Q55188040-6C16E7B4-3B7A-4992-BBBE-89808552773FQ56605730-CFC4DFA0-A9E5-4183-89B1-055AC1939A25Q57780524-6842A76A-7005-4E1C-95D3-5F6EC7DC3F91Q57780533-930CCD98-0ACC-4C2F-AAD1-6B208AF8A403Q57780535-AC4DF929-778A-41EA-9BBC-BB5154C6F167Q57780536-52A36F1C-BB20-4713-9131-C6EB409CEC15
P2860
[11C]choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
[11C]choline positron emission ...... ing prostate specific antigen.
@en
[11C]choline positron emission ...... ing prostate specific antigen.
@nl
type
label
[11C]choline positron emission ...... ing prostate specific antigen.
@en
[11C]choline positron emission ...... ing prostate specific antigen.
@nl
prefLabel
[11C]choline positron emission ...... ing prostate specific antigen.
@en
[11C]choline positron emission ...... ing prostate specific antigen.
@nl
P2093
P50
P1476
[11C]choline positron emission ...... ing prostate specific antigen.
@en
P2093
Cristina Messa
Francesco Montorsi
Giampiero Giovacchini
Luigi Gianolli
Rita Garcia-Parra
P304
P356
10.1016/J.JURO.2012.09.001
P407
P577
2012-11-16T00:00:00Z